# Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611

> **NCT01103011** · PHASE1 · COMPLETED · sponsor: **NeuroDerm Ltd.** · enrollment: 8 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** ND0611
- **DRUG:** ND0611

## Key facts

- **NCT ID:** NCT01103011
- **Lead sponsor:** NeuroDerm Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2010-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103011, "Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01103011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*